Neuromedical Sp. z o.o.
Research and development company focused on non-invasive neuromodulation therapies for cognitive impairment and early Alzheimer’s disease. Activities include preclinical electrophysiology research, development of a home-use transcutaneous vagus nerve stimulation device, multicentre clinical testing, collaboration with academic and commercial partners, and preparation for medical device certification supported by European funding.
Industries
Nr. of Employees
small (1-50)
Neuromedical Sp. z o.o.
Products
Home-use non-invasive neurostimulation system (headband form factor)
Headband-based non-invasive neurostimulation system for daily home use, incorporating stimulation electrodes and embedded stimulator electronics, intended for clinical testing in cognitive impairment and early Alzheimer’s disease.
Home-use non-invasive neurostimulation system (headband form factor)
Headband-based non-invasive neurostimulation system for daily home use, incorporating stimulation electrodes and embedded stimulator electronics, intended for clinical testing in cognitive impairment and early Alzheimer’s disease.
Services
Recruitment and enrollment of patients with mild cognitive impairment and early Alzheimer’s disease for device clinical studies.
Provision of patient and clinician user manuals and technical documentation after verification.
Recruitment and enrollment of patients with mild cognitive impairment and early Alzheimer’s disease for device clinical studies.
Provision of patient and clinician user manuals and technical documentation after verification.
Expertise Areas
- Non-invasive neuromodulation
- Home-use medical device engineering
- Preclinical electrophysiology and animal models
- Multicentre clinical trial management
Key Technologies
- Transcutaneous (auricular) vagus nerve stimulation
- In vivo hippocampal electrophysiology
- Embedded neurostimulator electronics
- Device-to-mobile communication for therapy parameter readout
News & Updates
Project to develop and conduct clinical trials of a personal brain stimulator for treatment of Alzheimer’s disease, funded under national and regional operational programmes. Planned outcomes included construction of a medical device and clinical trials.
Device reported to be undergoing conformity assessment and CE certification processes with expected clearance.
International multicentre double-blind clinical studies involving over 65 patients with reported safety and tolerability assessments.
Project to develop and conduct clinical trials of a personal brain stimulator for treatment of Alzheimer’s disease, funded under national and regional operational programmes. Planned outcomes included construction of a medical device and clinical trials.
Device reported to be undergoing conformity assessment and CE certification processes with expected clearance.
International multicentre double-blind clinical studies involving over 65 patients with reported safety and tolerability assessments.